Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Comprehensive Assessment of the Risk of Developing Coronary Artery Aneurysm in Kawasaki Disease: A KawaCOR Score
Stasa Krasic1,2, Srdjan Pasic2,3, Sanela Nikolic Tepic4
1Cardiology Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.
Insights
A new scoring system, KawaCOR, helps identify children at high risk for Kawasaki disease coronary artery aneurysms. A score of 5 or higher significantly increases the risk of developing these dangerous aneurysms.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Early identification of high-risk patients is crucial for Kawasaki disease (KD) treatment.
- Kawasaki disease can lead to coronary artery aneurysms (CAA), necessitating risk stratification.
- Developing a predictive scoring system for CAA and persistent giant CAA is essential.
Purpose of the Study:
- To develop and validate a novel scoring system, the KawaCOR score, for predicting CAA development in KD patients.
- To assess the score's ability to predict the persistence of giant CAA during follow-up.
- To aid in stratifying treatment algorithms for Kawasaki disease.
Main Methods:
- A retrospective cohort study of 151 patients with KD treated between 2011 and 2025.
- Development of a scoring system based on univariate analysis of clinical and laboratory parameters.
- Validation of the score using ROC curve analysis for sensitivity and specificity.
Main Results:
- 25 patients (16.5%) developed CAA; 9 had persistent aneurysms.
- The KawaCOR score incorporates age, IVIG duration, KD refractoriness, and laboratory markers (leukocytosis, neutrophilia, thrombocytosis, anemia, hypoproteinemia, hypoalbuminemia).
- A score ≥5 predicted CAA development (OR 8.7), and a score ≥8 predicted chronic giant CAA (OR 71.5). Score ≥5 showed 99% sensitivity and 70% specificity for CAA (AUC=0.87).
Conclusions:
- The KawaCOR score is the first regional system designed to predict CAA development in Kawasaki disease.
- The score effectively identifies patients at high risk for acute and chronic giant coronary artery aneurysms.
- Implementation of the KawaCOR score can improve risk stratification and management of KD patients.
Abstract:
Background: The early identification of high-risk patients is crucial in stratifying treatment algorithms for Kawasaki disease (KD). Our study aimed to develop a new scoring system to predict the risk of developing a coronary artery aneurysm (CAA) and the persistence of giant CAA during follow-up. Methods: A retrospective cohort study included 151 patients treated at our institute for KD between 2011 and 2025. Results: A total of 25 patients (16.5%) developed CAA, while, in the follow-up period, aneurysms were registered in nine patients. Based on the values obtained from the univariate analysis, a scoring system was developed. It included age <6 months, IVIG treatment for >7 days, refractory KD, leucocytosis (>17 × 109), neutrophilia (>16 × 109), thrombocytosis (>400 × 109), anaemia (<103 g/L), hypoproteinaemia (<54 g/L), and hypoalbuminaemia (<32 g/L). Patients with a score ≥5 had an almost nine-fold higher risk of developing CAA (OR 8.7, 95% CI 3.4-22.6; p < 0.001), while, if the score was ≥8, the risk for a chronic giant aneurysm was 71 times higher (OR 71.5, 95%CI 8.5-597.7; p < 0.001). Based on the ROC curve, a score ≥5 has 99% sensitivity and 70% specificity for the development of CAA (AUC = 0.87). A score ≥7 has 100% sensitivity and 85% specificity for the development of giant aneurysms (AUC = 0.87). Conclusions: The KawaCOR score is the first scoring system in our region specifically designed to predict the development of CAA and acute and chronic giant CAA.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

